EAC
Study Links Obesity Severity to Elevated Risk for BE and Esophageal Cancer
The risk of developing Barrett’s esophagus and esophageal adenocarcinoma increases with severity of obesity, ...
JULY 9, 2025
BE Indefinite for Dysplasia Requires Close Follow-up in Year After Diagnosis
Management of Barrett’s esophagus patients who have tissue that is indefinite for dysplasia hasn’t ...
OCTOBER 23, 2024
Visceral Fat May Play a Role in EAC Development
Visceral abdominal fat may contribute to the development of adenocarcinoma in patients with long-segment ...
OCTOBER 27, 2023
EAC Screening Strategies Based On GERD Alone Are Missing the Boat
SAN DIEGO—Gastroesophageal reflux disease is the most common indication for esophagogastroduodenoscopy ...
OCTOBER 10, 2022
The Role of Biomarkers In the Management Of Barrett’s Esophagus
It is well established that selected patients with high-grade dysplasia (HGD)/esophageal adenocarcinoma (EAC) ...
OCTOBER 26, 2020
The Role of Chemoprevention in Patients With Barrett’s Esophagus
The prevalence of gastroesophageal reflux disease (GERD) and esophageal adenocarcinoma (EAC) has been increasing, ...
JULY 24, 2017